The United Laboratories International Holdings Limited (ULIHF)

Market Cap	3.30B +21.8%
Revenue (ttm)	1.97B +0.7%
Net Income	427.51M +5.3%
EPS	0.24 +5.3%
Shares Out	n/a
PE Ratio	7.73
Forward PE	8.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	900
Average Volume	6,928
Open	1.875
Previous Close	2.277
Day's Range	1.875 - 1.875
52-Week Range	1.150 - 2.350
Beta	0.11
RSI	54.52
Earnings Date	Mar 27, 2026

About ULIHF

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 17,400
• Stock Exchange: OTCMKTS
• Ticker Symbol: ULIHF

Financial Performance

In 2024, ULIHF's revenue was 13.76 billion, an increase of 0.14% compared to the previous year's 13.74 billion. Earnings were 2.66 billion, a decrease of -1.54%.

Financial numbers in CNY